(1) Rismanbaf A. Potential treatments for COVID-19; a narrative literature review. Arch. Aca. Emerg. Med. (2020) 8: 1-4.
(2) Hosseini FS and Amanlou M. Simeprevir, potential candidate to repurpose for coronavirus infection: virtual screening and molecular docking study. Preprints (2020). Available from: URL: https://www.preprints.org/manuscript/202002.0438/v1.
(3) Fan K, Ma L, Han X, Liang H, Wei P, Liu Y and Lai L. The substrate specificity of SARS coronavirus 3C-like proteinase. Biochem. Biophys. Res. Commun. (2005) 329: 934-40.
(4) Xu C, Ke Z, Liu C, Wang Z, Liu D, Zhang L, Wang J, He W, Xu Z and Li Y. Systemic in silico screening in drug discovery for coronavirus disease (COVID-19) with an online interactive web server. J. Chem. Inf. Model. (2020) 60: 5735–45.
(5) Elmezayen AD, Al-Obaidi A, Şahin AT, and Yelekçi K. Drug repurposing for coronavirus (COVID-19): in-silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes. J. Biomol. Struct. Dyn. (2020) 1-12.
(6) Jin Z, Du X, Xu Y, Deng Y, Liu M, Zhao Y, Zhang B, Li X, Zhang L, and Duan Y. Structure of Mpro from COVID-19 virus and discovery of its inhibitors. Nature. (2020) 582: 289-93.
(7) Khan MF, Khan MA, Khan ZA, Ahamad T and Ansari WA. Identification of Dietary Molecules as Therapeutic Agents to Combat COVID-19 Using Molecular Docking Studies. Preprints (2020). Available from: URL: https://www.researchsquare.com/article/rs-19560/v1.
(8) Saakre M, Mathew D and Ravisankar V. Perspectives on plant flavonoid quercetin-based drugs for novel SARS-CoV-2. Beni-Suef Univ. J. Basic Appl. Sci. (2021) 10: 1-13.
(9) Kumar S, Sharma PP, Shankar U, Kumar D, Joshi SK, Pena L, Durvasula R, Kumar A, Kempaiah P and Poonam. Discovery of new hydroxyethylamine analogs against 3CLpro protein target of SARS-CoV-2: Molecular docking, molecular dynamics simulation, and structure–activity relationship studies. J. Chem. Inf. Model. (2020) 60: 5754–70.
(10) Khaerunnisa S, Kurniawan H, Awaluddin R, Suhartati S and Soetjipto S. Potential inhibitor of COVID-19 main protease (Mpro) from several medicinal plant compounds by molecular docking study. Preprints (2020). Available from: URL: https://www.preprints.org/manuscript/202003.0226/v1.
(11) Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS and Olson AJ. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. (2009) 30: 2785-91.
(12) Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK and Olson AJ. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. (1998) 19: 1639-62.
(13) Makarewicz T and Kaźmierkiewicz R. Molecular dynamics simulation by GROMACS using GUI plugin for PyMOL. J. Chem. Inf. Model. (2013) 53: 1229–34.
(14) Release S. Schrödinger Suite 2015-2 Protein Preparation Wizard; Epik version 3.2, Schrödinger, LLC, New York (2015). Available from: URL: https://www.schrodinger.com/citations.
(15) Release S. Epik, version 3.4. Schrödinger, LLC, New York (2015). Available from: URL: https://www.schrodinger.com/citations.
(16) Jorgensen WL, Maxwell DS and Tirado-Rives J. Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J. Am. Chem. Soc. (1996) 118: 11225-36.
(17) Release S. LigPrep, version 3.3, Schrödinger. New York (2015). Available from: URL: https://www.schrodinger.com/citations.
(18) Schrödinger L. Schrödinger Suite 2015-2, Protein Preparation Wizard, Epik version 3.2. New York (2015). Available from: URL: https://www.schrodinger.com/citations.
(19) Zhong H, Tran LM and Stang JL. Induced-fit docking studies of the active and inactive states of protein tyrosine kinases. J. Mol. Graph. Model. (2009) 28: 336-46.
(20) Schrödinger L. Induced fit docking. New York (2015). Available from: URL: https://www.schrodinger.com/citations.
(21) Huang N, Kalyanaraman C, Irwin JJ and Jacobson MP. Physics-based scoring of protein− ligand complexes: Enrichment of known inhibitors in large-scale virtual screening. J. Chem. Inf. Model. (2006) 46: 243-53.
(22) Lyne PD, Lamb ML and Saeh JC. Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring. J. Med. Chem. (2006) 49: 4805-8.
(23) Massova I and Kollman PA. Combined molecular mechanical and continuum solvent approach (MM-PBSA/GBSA) to predict ligand binding. Perspect. Drug Discov. Des. (2000) 18: 113-35.
(25) Abraham MJ, Murtola T, Schulz R, Páll S, Smith JC, Hess B and Lindahl E. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. (2015) 1: 19-25.
(26) Cornell WD, Cieplak P, Bayly CI, Gould IR, Merz KM, Ferguson DM, Spellmeyer DC, Fox T, Caldwell JW and Kollman PA. A second generation force field for the simulation of proteins, nucleic acids, and organic molecules. J. Am. Chem. Soc. (1995) 117: 5179-97.
(27) Da Silva AWS and Vranken WF. ACPYPE-Antechamber python parser interface. BMC Res. Notes (2012) 5: 367.
(28) Søndergaard CR, Olsson MH, Rostkowski M and Jensen JH. Improved treatment of ligands and coupling effects in empirical calculation and rationalization of p K a values. J. Chem. Theory Comput. (2011) 7: 2284-95.
(29) Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW and Klein ML. Comparison of Simple Potential Functions for Simulating Liquid Water. J. Chem. Phys. (1983) 79: 926.
(30) Humphrey W, Dalke A, and Schulten K. VMD: visual molecular dynamics. J. Mol. Graph. (1996) 14: 33-8.
(31) Cosconati S, Forli S, Perryman AL, Harris R, Goodsell DS and Olson AJ. Virtual screening with AutoDock: theory and practice. Expert Opin. Drug Discov. (2010) 5: 597-607.